News

Hims & Hers achieved 136% YoY subscriber growth and unveiled ambitious 2030 goals. Discover how precision medicine drives ...
Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo ...
Hims & Hers, the telehealth and wellness company, has hired a veteran of the autonomous vehicle industry as its next chief ...
Hims & Hers continues to deliver strong revenue growth. Meanwhile, the company surprised investors by offering a long-term ...
Andrew Dudum cofounded online pharmacy Hims & Hers eight years ago, when he was 27 years old. He’s now the latest to make a ...
Hims & Hers ( HIMS 19.03%) stock soared 18.2% in trading on Tuesday after the company reported first-quarter revenue growth ...
A post-earnings rally in Hims & Hers Health Inc. has turned co-founder and Chief Executive Officer Andrew Dudum into a weight ...
Hims & Hers shares fell in extended trading on Monday after the company reported first-quarter earnings that offered soft ...
The decline in Hims & Hers’ stock price comes as the market reacts to the potential dilution of shares resulting from the ...
Nader Kabbani, who spent almost 20 years at the e-commerce giant, joins the health startup as chief operations officer.
Here are the latest rating downgrades by Seeking Alpha analysts: British American Tobacco (NYSE:BTI). Hold to sell by Michael ...
The FDA has received reports of erectile dysfunction, anxiety, and more after using topical finasteride, a popular hair loss medication. Experts say the medication is still safe for many, but you ...